AstraZeneca says could begin COVID-19 vaccine production early in 2021

MEXICO CITY (Reuters) - Production of 400 million doses of a COVID-19 vaccine for Latin America could begin early next year, an executive for pharmaceutical company AstraZeneca Plc (AZN.L) said on Thursday, as the region’s coronavirus death toll stands at nearly 230,000.